Financhill
Back

Galectin Therapeutics Quote, Financials, Valuation and Earnings

Galectin Therapeutics Price Quote

$2.75
+0.06 (+2.23%)
(Updated: November 19, 2024 at 5:55 PM ET)

Galectin Therapeutics Key Stats

Sell
40
Galectin Therapeutics (GALT) is a Sell

Day range:
$2.65 - $2.85
52-week range:
$1.56 - $4.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
174K
Avg. volume:
140.3K
1-year change:
37.24%
Market cap:
$168.8M
Revenue:
$0
EPS:
$-0.73

How Much Does Galectin Therapeutics Make?

Data Unavailable

Is Galectin Therapeutics Growing As A Company?

Data Unavailable

Galectin Therapeutics Stock Price Performance

What Is Galectin Therapeutics 52-Week High & Low?

Galectin Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Galectin Therapeutics?

Is Galectin Therapeutics Cash Flow Positive?

  • What Is GALT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.7M
  • What Is Galectin Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $40.4M
  • What Is Galectin Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Galectin Therapeutics Return On Invested Capital

Data Unavailable

Galectin Therapeutics Earnings Date & Stock Price

Galectin Therapeutics Competitors

Galectin Therapeutics Dividend Yield

Galectin Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.00
Upside from Last Price: 308.92%

Major Shareholders

  • How many GALT shares are owned by institutional investors?
    13.6M GALT shares are owned by institutional investors
  • How many GALT shares are owned by insiders?
    16.1M GALT shares are owned by insiders